KVUE.NYSEKenvue INC

Form 4: Kenvue Director Richard Allison Jr. Acquires Deferred Share Units as Part of Compensation Plan

Sentiment:

Insider Transaction Report


Kenvue Inc. Director Richard E. Allison Jr. acquired 7,659 Deferred Share Units (DSUs) on May 22, 2025, as part of the company's director compensation plan, increasing his total beneficial ownership to 31,249.536 DSUs.

Summary

  • Richard E. Allison Jr., a Director of Kenvue Inc. (KVUE), acquired 7,659 Deferred Share Units (DSUs).
  • The transaction occurred on May 22, 2025.
  • These DSUs were granted under Kenvue's Amended and Restated Deferred Fee Plan for Directors.
  • Each DSU represents the right to receive one share of Kenvue's common stock upon the termination of Mr. Allison's directorship.
  • The reported price of the derivative security (DSU) was $23.5.
  • Following this acquisition, Mr. Allison beneficially owns 31,249.536 DSUs.
  • The total beneficial ownership includes DSUs acquired as dividend equivalents.

Sentiment

Score: 7

Explanation: The filing reports a routine compensation-related acquisition of equity by a director, which is generally viewed positively as it aligns management interests with shareholders. There are no negative implications or red flags.

Positives

  • Acquisition of DSUs by a director indicates alignment of interests with shareholders, as the value of DSUs is tied to the company's common stock performance.
  • The grant is part of a structured compensation plan, suggesting a standard practice for director remuneration.

Future Outlook

This Form 4 filing primarily reports a past transaction and does not contain explicit forward-looking statements or guidance regarding Kenvue's future performance. The DSUs are designed to align director interests with long-term shareholder value, with settlement upon termination of directorship.

Management Comments

  • The filing notes that the Deferred Share Units are to be settled in shares of the Issuer's common stock upon termination of the Reporting Person's directorship (with each DSU representing the right to receive one share of Common Stock on the settlement date).
  • It also clarifies that the total beneficial ownership includes DSUs acquired as dividend equivalents.

Industry Context

This transaction is a routine insider filing common across publicly traded companies, where directors receive equity-based compensation to align their interests with long-term shareholder value. Kenvue, as a consumer health company, typically uses such mechanisms to retain and incentivize its leadership, a practice consistent with broader industry standards for corporate governance and executive compensation.

Comparison to Industry Standards

  • The grant of Deferred Share Units (DSUs) as part of director compensation is a common practice among large consumer health and pharmaceutical companies, such as Procter & Gamble (PG), Johnson & Johnson (JNJ), and Colgate-Palmolive (CL), which often use equity-based awards to align director incentives with long-term shareholder returns.
  • The structure, where DSUs convert to common stock upon termination of service, is a standard deferred compensation mechanism, similar to plans observed at companies like Pfizer (PFE) or Unilever (UL), ensuring directors have a vested interest in the company's sustained performance.
  • The reported price of $23.5 per DSU aligns with Kenvue's common stock trading range around the transaction date, indicating a market-based valuation for the compensation.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Compensation Plan UtilizationGrant of Deferred Share Units (DSUs) under the Issuer's Amended and Restated Deferred Fee Plan for Directors.05/22/2025Reinforces alignment of director interests with long-term shareholder value by tying compensation to equity performance and deferring settlement until directorship termination.

Stakeholder Impact

  • Shareholders: The acquisition of DSUs by a director aligns their interests with shareholders, as the value of the DSUs is directly tied to the company's stock performance, potentially encouraging decisions that enhance long-term shareholder value.
  • Directors: This transaction reflects the compensation structure for directors, providing them with equity-based incentives.

Next Steps

  • The DSUs will be settled in shares of Kenvue's common stock upon the termination of Mr. Allison's directorship.

Key Dates

DateDescription
05/22/2025Date of transaction (acquisition of Deferred Share Units)
05/27/2025Date Form 4 was signed by attorney-in-fact

Recommendation

hold

Keywords

Kenvue Inc., KVUE, Form 4, SEC filing, Deferred Share Units, DSUs, Director compensation, Insider transaction, Beneficial ownership, Richard E. Allison Jr.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.